Europejskie Centrum Odszkodowań SA Cash Flow Conversion Efficiency
Europejskie Centrum Odszkodowań SA cash flow conversion efficiency. Based on the latest financial reports, Europejskie Centrum Odszkodowań SA (EUC) has a cash flow conversion efficiency ratio of 0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-179.00K ≈ $-49.26K USD) by net assets (zł-80.93 Million ≈ $-22.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Europejskie Centrum Odszkodowań SA (2011–2024)
Cash flow conversion efficiency of Europejskie Centrum Odszkodowań SA from 2011 to 2024. This chart illustrates how Europejskie Centrum Odszkodowań SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Europejskie Centrum Odszkodowań SA stock price for real-time trading data and today's change.
Europejskie Centrum Odszkodowań SA Cash Flow Conversion Ratio Explained
Europejskie Centrum Odszkodowań SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Europejskie Centrum Odszkodowań SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Europejskie Centrum Odszkodowań SA ranked by their cash flow conversion efficiency. Also see Europejskie Centrum Odszkodowań SA (EUC) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shree Ram Proteins Limited
NSE:SRPL
|
0.086x |
|
LABOCANNA S.A. ZY-10
F:9Y2
|
-0.139x |
|
Tessin Nordic Holding AB
ST:TESSIN
|
0.101x |
|
Veganz Group AG
F:VEZ
|
-0.582x |
|
Speedy Hire PLC
LSE:SDY
|
0.278x |
|
Waverley Pharma Inc
V:WAVE
|
0.024x |
|
Maven Income And Growth Vct 3 Plc
LSE:MIG3
|
-0.009x |
|
Enveric Biosciences Inc
NASDAQ:ENVB
|
-0.600x |
Annual Cash Flow Conversion Efficiency for Europejskie Centrum Odszkodowań SA (2011–2024)
The table below shows the annual cash flow conversion efficiency of Europejskie Centrum Odszkodowań SA from 2011 to 2024. Review Europejskie Centrum Odszkodowań SA free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | zł-81.54 Million ≈ $-22.44 Million |
zł-456.00K ≈ $-125.50K |
0.006x | +203.24% |
| 2023-12-31 | zł-91.94 Million ≈ $-25.30 Million |
zł498.00K ≈ $137.06K |
-0.005x | +96.70% |
| 2022-12-31 | zł-80.08 Million ≈ $-22.04 Million |
zł13.14 Million ≈ $3.62 Million |
-0.164x | -180.21% |
| 2021-12-31 | zł35.33 Million ≈ $9.72 Million |
zł7.23 Million ≈ $1.99 Million |
0.205x | +42.10% |
| 2020-12-31 | zł55.69 Million ≈ $15.33 Million |
zł8.02 Million ≈ $2.21 Million |
0.144x | -57.88% |
| 2019-12-31 | zł45.60 Million ≈ $12.55 Million |
zł15.58 Million ≈ $4.29 Million |
0.342x | +966.26% |
| 2018-12-31 | zł43.30 Million ≈ $11.92 Million |
zł1.39 Million ≈ $382.00K |
0.032x | -93.62% |
| 2017-12-31 | zł46.99 Million ≈ $12.93 Million |
zł23.62 Million ≈ $6.50 Million |
0.503x | +207.78% |
| 2016-12-31 | zł55.55 Million ≈ $15.29 Million |
zł9.07 Million ≈ $2.50 Million |
0.163x | -28.29% |
| 2015-12-31 | zł48.32 Million ≈ $13.30 Million |
zł11.01 Million ≈ $3.03 Million |
0.228x | -72.89% |
| 2014-12-31 | zł40.97 Million ≈ $11.27 Million |
zł34.43 Million ≈ $9.47 Million |
0.840x | +596.26% |
| 2013-12-31 | zł22.87 Million ≈ $6.29 Million |
zł2.76 Million ≈ $759.59K |
0.121x | -31.63% |
| 2012-12-31 | zł26.81 Million ≈ $7.38 Million |
zł4.73 Million ≈ $1.30 Million |
0.177x | +552.85% |
| 2011-12-31 | zł19.24 Million ≈ $5.30 Million |
zł-750.00K ≈ $-206.41K |
-0.039x | -- |
About Europejskie Centrum Odszkodowań SA
Europejskie Centrum Odszkodowan S.A. engages in the provision of legal and financial assistance to people injured in accidents and their relatives in obtaining compensation from insurance companies in Poland, the Czech Republic, Slovakia, Hungary, and Romania. The company was founded in 2004 and is headquartered in Legnica, Poland.